Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation

被引:61
作者
Billiard, Fabienne [1 ]
Litvinova, Elena [1 ]
Saadoun, David [1 ]
Djelti, Fathia [1 ]
Klatzmann, David [1 ]
Cohen, Jose L. [1 ]
Marodon, Gilles [1 ]
Salomon, Benoit L. [1 ]
机构
[1] Univ Paris 06, CNRS, UMR 7087, Hop La Pitie Salpetriere, F-75013 Paris, France
关键词
D O I
10.4049/jimmunol.177.4.2167
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the in vivo conditions in which CD4(+)CD25(+) regulatory T cells (T,,g) exert their suppressive effect in nonlymphopenic mice. To this end, we analyzed T-reg-mediated suppression of expansion and cytokine production at different levels of Ag-specific CD4(+)CD25(-) T cell activation. Using Ab-mediated depletion of endogenous T-reg, we show that basal immunosuppression is dependent on effector T cell activation. These polyclonal T-reg, which were poorly activated in our immunization conditions, were effective in weak but not high T cell activation context. In contrast, the same immunization conditions led to proliferation of cotransferred Ag-specific T-reg. Those efficiently inhibited T cell proliferation and cytokine production even in strong T cell activation context. Interestingly, T-reg selectively suppressed expansion or cytokine production depending on the experimental approach. The importance of the immune context for efficient suppression is further supported by the observation that T-reg depletion exacerbated diabetes of NOD mice only at the early stage of the disease. Overall, our study suggests that T-reg-mediated suppression depends on the relative activation of T-reg and effector T cells in vivo. This balance may be a critical factor in the regulation of immune responses.
引用
收藏
页码:2167 / 2174
页数:8
相关论文
共 52 条
[31]  
Onizuka S, 1999, CANCER RES, V59, P3128
[32]  
Papiernik M, 1997, J IMMUNOL, V158, P4642
[33]   Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells [J].
Pasare, C ;
Medzhitov, R .
SCIENCE, 2003, 299 (5609) :1033-1036
[34]   Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes [J].
Pop, SM ;
Wong, CP ;
Culton, DA ;
Clarke, SH ;
Tisch, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1333-1346
[35]   Myelin proteolipid protein-specific CD4+ CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis [J].
Reddy, J ;
Illes, Z ;
Zhang, XM ;
Encinas, J ;
Pyrdol, J ;
Nicholson, L ;
Sobel, RA ;
Wucherpfennig, KW ;
Kuchroo, VK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (43) :15434-15439
[36]   Interferon γ is required for activation-induced death of T lymphocytes [J].
Refaeli, Y ;
Van Parijs, L ;
Alexander, SI ;
Abbas, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :999-1005
[37]   Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses [J].
Sakaguchi, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :531-562
[38]   B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes [J].
Salomon, B ;
Lenschow, DJ ;
Rhee, L ;
Ashourian, N ;
Singh, B ;
Sharpe, A ;
Bluestone, JA .
IMMUNITY, 2000, 12 (04) :431-440
[39]   A ROLE FOR NON-MHC GENETIC-POLYMORPHISM IN SUSCEPTIBILITY TO SPONTANEOUS AUTOIMMUNITY [J].
SCOTT, B ;
LIBLAU, R ;
DEGERMANN, S ;
MARCONI, LA ;
OGATA, L ;
CATON, AJ ;
MCDEVITT, HO ;
LO, D .
IMMUNITY, 1994, 1 (01) :73-82
[40]   HISTOLOGICAL STUDY OF PANCREATIC BETA-CELL LOSS IN RELATION TO THE INSULITIS PROCESS IN THE NONOBESE DIABETIC MOUSE [J].
SIGNORE, A ;
PROCACCINI, E ;
TOSCANO, AM ;
FERRETTI, E ;
WILLIAMS, AJK ;
BEALES, PE ;
CUGINI, P ;
POZZILLI, P .
HISTOCHEMISTRY, 1994, 101 (04) :263-269